Table 3.
The association between NAFLD and H. pylori infection in different subgroups.
| Variable | Number of patients with fatty liver (%) | H. pylori | |||
|---|---|---|---|---|---|
| Crude OR (95% CI) | P | ∗Adjusted OR (95% CI) | P | ||
| Age | |||||
| <45 | 2272 (21.6) | 1.624 (1.479-1.783) | <0.001 | 1.679 (1.516-1.860) | <0.001 |
| ≥45 | 2553 (34.3) | 1.534 (1.393-1.689) | <0.001 | 1.604 (1.449-1.776) | <0.001 |
| Gender | |||||
| Female | 1350 (22.9) | 1.435 (1.269-1.621) | <0.001 | 1.418 (1.241-1.620) | <0.001 |
| Male | 3475 (28.8) | 1.680 (1.551-1.818) | <0.001 | 1.761 (1.617-1.918) | <0.001 |
| Number of metabolic syndromes | |||||
| 0 | 175 (7.1) | 1.068 (0.931-1.225) | 0.347 | 0.964 (0.702-1.323) | 0.819 |
| 1-2 | 2291 (22.0) | 1.267 (1.121-1.431) | <0.001 | 1.233 (1.121-1.357) | <0.001 |
| ≥3 | 2359 (46.2) | 2.535 (2.264-2.839) | <0.001 | 2.811 (2.497-3.163) | <0.001 |
∗Adjusted for age, gender, underlying diseases, and MS.